$HYPE H4 Outlook
HYPE is a token traded in the crypto market, with utility focused on blockchain adoption within specific ecosystems like DeF, or community-driven use cases. Hyperliquid has recently achieved significant milestones in trading volumes, particularly in decentralized perpetual swaps. As of December 13, 2024, the platform’s cumulative perpetuals trading volume surpassed $500 billion, marking a 15-fold increase within the year.In terms of daily activity, Hyperliquid recorded an average daily trading volume exceeding $5 billion, accounting for over 45% of the total on-chain perpetuals market. Notably, Ether (ETH) perpetuals led this activity, with a trading volume of $7 billion over a recent week, surpassing Bitcoin’s (BTC) $5.94 billion in the same period.
Based on H4 chart:
1. Liquidity Zones
• Sell Side Liquidity is observed around $25.401 and $20.832, indicating stop-loss zones or short positions that could be targeted by bearish price moves.
• Buy Side Liquidity exists near $35.845 and at 1.618 $42.093, suggesting potential areas for price surges if bullish momentum builds.
2. Price Structure & Tren
• The price is currently consolidating with potential for a breakout above resistance levels.
• The SMA 13 (yellow line) and SMA 21 (blue line) are attempting a golden cross, which typically signals the start of bullish momentum. However, further confirmation is needed to verify this trend.
3. Relative Strength Index (RSI)
• RSI is in the neutral zone near 50, indicating no significant bullish or bearish momentum yet. However, the upward trend in RSI suggests increasing buying pressure.
4. Price Movement Projections
• Bullish Scenario: If the price breaks above resistance at $35.654 and captures liquidity above the Buy Side Liquidity zone, the next target would be $42.016 (Fibonacci extension level 1.618)
• Bearish Scenario: If the price fails to hold above $25.401, it could retest the Sell Side Liquidity zone at $23.533 or even $20.832 as a strong support level.
Order cancelled
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.